TABLE 1.
Demographic Characteristics of the Study
| Diagnosis | ||||||
|---|---|---|---|---|---|---|
| Controls | POTS | PASC | ||||
| N | 15 | 10 | 9 | 95% CI, F, and p (Controls‐POTS‐PASC) | p (POTS‐PASC) | |
| Age, years, mean (SD) | 40.1 (11.6) | 36.3 (9.8) | 35.8 (7.3) | 33.7–41.0, F (2, 31) = 0.661, p = 0.524 | 0.993 | |
| Gender, n (%) | F | 13 (86.7) | 9 (90.0) | 9 (100) | p = 0.531 | 0.999 |
| M | 2 (13.3) | 1 (10.0) | ||||
| BMI, kg/m2, mean (SD) | 25.3 (5.9) | 23.6 (4.8) | 26.4(7.3) | 22.90–27.1, F (2, 31) = 0.508, p = 0.607 | 0.578 | |
| Symptom duration, years, mean (SD) | 0.0 (0.0) | 7.7 (4.3) | 0.8 (0.3) | 2.01–3.68, F (2, 31) = 35.7, p < 0.001 | <0.001 | |
BMI = body mass index; CI = confidence interval; F = bioavailability; PASC = post‐acute sequelae of coronavirus disease 2019; POTS = postural tachycardia syndrome.